LASA SUPERGENERICS LTD Intrinsic Value
LASA · Healthcare · Current price ₹7.11
Is LASA SUPERGENERICS LTD undervalued?
DocStoX estimates the fair value of LASA SUPERGENERICS LTD at ₹6 per share, versus the current market price of ₹7. That puts the stock about -15.6% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹6). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹5 (bear) to ₹6 (base) to ₹7 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹7 versus an intrinsic value of ₹6, LASA SUPERGENERICS LTD currently offers -15.6% of negative margin (i.e. a premium).
More on LASA SUPERGENERICS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.